C-reactive protein and D-dimer with clinical probability score in the exclusion of pulmonary embolism
|
|
- Henry Johnston
- 5 years ago
- Views:
Transcription
1 research paper C-reactive protein and D-dimer with clinical probability score in the exclusion of pulmonary embolism N. Steeghs, 1 R. J. Goekoop, 1 R. W. L. M. Niessen, 2 G. J. P. M. Jonkers, 3 H. Dik 4 and M. V. Huisman 1 1 Department of General Internal Medicine, Leiden University Medical Centre, Leiden, 2 Department of Clinical Chemistry, Rijnland Hospital, Leiderdorp, 3 Department of Internal Medicine, Rijnland Hospital, Leiderdorp, and 4 Department of Pulmonary Medicine, Rijnland Hospital, Leiderdorp, the Netherlands Received 23 March 2005; accepted for publication 8 June 2005 Correspondence: N. Steeghs, Department of General Internal Medicine C1-R41, Leiden University Medical Centre, Albinusdreef 2, PO Box 9600, 2300 RC Leiden, the Netherlands. n.steeghs@lumc.nl Summary This study evaluated the diagnostic value of C-reactive protein (CRP) combined with a clinical decision rule in the exclusion of pulmonary embolism () and compared this with D-dimer. In 363 consecutive outpatients CRP and D-dimer test were performed and clinical probability of was assessed. Patients with D-dimer levels <500 lg/l and clinical probability indicating unlikely were followed for 3 months. Ventilation-perfusion scan or spiral computerized tomography was performed in patients with D-dimer levels 500 lg/l or clinical probability indicating likely. The CRP had a sensitivity of 95Æ7% [95% confidence interval (CI): ] and negative predictive value (NPV) of 98Æ4% (96 100). CRP <5 mg/l with clinical probability score indicating unlikely (n ¼ 108, 30%), had a sensitivity of 96Æ7% (90 100), a specificity of 43Æ0% (37 49) and NPV of 99Æ1% (97 100). D-dimer <500 lg/l with clinical probability score indicating unlikely (n ¼ 170, 51%), had a sensitivity of 96Æ7% (90 100), a specificity of 67Æ9% (62 74) and NPV of 99Æ4% (98 100). Based on retrospective data it was concluded that a standard CRP test can potentially be used to safely exclude, either as a sole test or combined with clinical probability assessment. Prospective studies are needed to confirm these findings. Keywords: clinical probability assessment, C-reactive protein, D-dimer, pulmonary embolism. Objective testing for pulmonary embolism () is crucial, because clinical assessment alone was found to be incorrect in up to 50% of cases and the mortality rate of untreated is high (Cooper et al, 1992). Algorithms to rule out or diagnose often involve ventilation-perfusion (V/Q) scans, spiral computerized tomography (CT), or pulmonary angiography, which are invasive, complex and time-consuming. On the contrary, an incorrect diagnosis of and therefore unnecessary treatment with anticoagulant therapy is associated with a risk of bleeding. New simple tests are therefore warranted to rule out and to reduce the number of sophisticated imaging techniques needed. Increased levels of serum C-reactive protein (CRP), a marker of systemic inflammation, have been reported in patients with venous thrombosis and (Roumen-Klappe et al, 2002). The CRP assay is cheap and readily available 24 h a day in most hospitals. Few studies, involving either small numbers of patients or lacking appropriate study methodology, have evaluated the diagnostic utility of CRP measurement in the exclusion of. Results have been diverse, with reported sensitivities of the CRP assay ranging from 60 to 100% depending on cut-off levels of between 5 and 10 mg/l (Thomas et al, 1989; Syrjala et al, 1990; Jossang & Runde, 1992; Franco et al, 1994; Wong et al, 1996; Horney & Lagerstedt, 1998; Maskell & Butland, 2001; Bucek et al, 2002; Aujesky et al, 2003). The specificities in these studies ranged from 52 to 78%. Importantly, the negative predictive values (NPVs) ranged from 76 to 100%. Three studies have evaluated the CRP test in patients with clinical suspected (Cooper et al, 1992; Franco et al, 1994; Aujesky et al, 2003), but only one has evaluated the value of the CRP assay combined with clinical probability assessment (Aujesky et al, 2003). In this study, the CRP alone had a sensitivity of 84% and a NPV of 87% at a CRP cut-off level of 5 mg/l. The NPV increased to 97% when combined doi: /j x ª 2005 Blackwell Publishing Ltd, British Journal of Haematology, 130,
2 C-reactive Protein in Pulmonary Embolism with a low clinical probability. However, the lower 95% confidence limit (CI) of 89% led the authors to conclude that the CRP test, either alone or in combination with a clinical prediction rule, cannot be used as a safe test to exclude without further testing. In view of the very limited evaluation of CRP, especially in combination with other non-invasive tests, additional studies to validate the use of CRP testing in patients with suspected are needed. The aim of our study was to determine whether CRP alone or in combination with a clinical prediction rule is an alternative to D-dimer as a laboratory marker in the diagnostic work-up of patients with suspected. This study was performed as part of a large prospective trial testing a new diagnostic algorithm for, based on clinical probability assessment and D-dimer test (unpublished observations). Patients and methods Patients Between March 2002 and December 2003 we prospectively screened consecutive patients presenting with suspected to the emergency department or outpatient clinic of a teaching hospital in Leiderdorp, the Netherlands. Inclusion criteria were as follows: (i) presentation to the emergency department or outpatient clinic and (ii) suspected. Exclusion criteria were as follows: (i) age <18 years, (ii) ongoing anticoagulation for >24 h, (ii) pregnancy, (iv) allergy to contrast material, (v) expected survival <3 months, (vi) venous thromboembolism in the previous 6 months and (vii) refusal or inability to consent. Patients with all inclusion criteria and no exclusion criteria were eligible. The hospital s institutional review board approved the protocol. Diagnostic work-up Doctors of the emergency department or outpatient clinic assessed the clinical probability of in all eligible patients, using the clinical decision rule described by Wells et al (1998). A score of 4Æ0 was designated as unlikely and a score of >4Æ0 as likely, based on the previous use of the Wells score in combination with D-dimer testing (Wells et al, 2005). In all patients a common immunoturbidimetric CRP test (Tinaquant, Roche diagnostics, Mannheim, Germany) was performed. In patients with a clinical probability score indicating unlikely a quantitative rapid enzyme-linked immunosorbent assay (ELISA) D-dimer assay (Vidas DD, biomérieux, Marcy l Etoile, France) was performed. The CRP cut-off level was 5 mg/l and the D-dimer cut-off level was 500 lg/l according to previous studies (Ginsberg et al, 1995; Aujesky et al, 2003; Perrier et al, 2004). All analyses were done at admittance on fresh plasma and were performed by technicians, who were unaware of the results of other tests for or clinical status of the patients. A was ruled out in patients with a clinical probability score indicating unlikely and D-dimer level <500 lg/l; these patients did not undergo further diagnostic procedures and anticoagulation treatment was withheld in these cases. In patients with a clinical probability score indicating likely or a D-dimer level 500 lg/l, either V/Q lung scanning or spiral CT was performed. A normal perfusion scan ruled out, and a high probability V/Q scan established the diagnosis (The PIOD Investigators, 1990). In patients with a low/ moderate probability V/Q scan a CT was performed. A CT was positive for if contrast material outlined a central intraluminal defect or if a vessel was totally occluded in at least two different projections (Perrier et al, 2001). All patients with objectively confirmed were hospitalized and treated with anticoagulants. Follow up All patients were followed by their primary care doctors. Patients were instructed to contact their doctor when signs or symptoms of venous thromboembolism recurred. Upon suspicion, objective testing for deep venous thrombosis (compression ultrasonography) or (V/Q lung scanning or spiral CT) was carried out. Patients with a clinical probability score indicating unlikely and D-dimer <500 lg/l were seen in the outpatient clinic after 3 months, or were interviewed by telephone after at least 3 months when a visit to the hospital was not possible. Of the patients who died in the 3-month follow up, the cause of death, including fatal, was determined from the medical record or through contact with the treating doctor. For both the CRP and the D-dimer test the 3-month follow-up information was used as the reference test for the diagnosis of. In patients with a clinical probability score indicating unlikely and D-dimer levels <500 lg/l, an uneventful 3-month follow up was interpreted as confirmation of exclusion of. The CRP testing was not used in the management strategy, but results were prospectively collected. Analysis of the data were performed retrospectively. Statistical analysis Statistical analysis was performed with the Statistical Package for the Social Sciences (spss) version 11.0 (SPSS, Chicago, IL, USA). For the CRP and D-dimer, the test characteristics and predictive values with their 95% confidence intervals (CIs) were calculated according to the clinical probability class. The areas beneath the receiver operating characteristics (ROC) curves were used to compare the discriminative power of the CRP and D-dimer test in diagnosing or ruling out. Results During the investigation period 363 consecutive patients with suspected were identified. Twenty-one patients (5Æ8%) were ª 2005 Blackwell Publishing Ltd, British Journal of Haematology, 130,
3 N. Steeghs et al excluded because of age <18 years (n ¼ 3), ongoing anticoagulation for >24 h (n ¼ 9), pregnancy (n ¼ 2), allergy to contrast material (n ¼ 2), expected survival <3 month (n ¼ 1), venous thromboembolism in the previous 6 months (n ¼ 5), and refusal or inability to give consent (n ¼ 1). Two patients each had two excluding factors present. In eight patients (2Æ2%) no CRP measurement was performed and one patient (0Æ3%) did not have a D-dimer measurement performed. Two patients were lost to follow up (0Æ6%). Baseline characteristics of the study population of 331 patients are shown in Table I. Forty-seven patients were found to have (14Æ2%). was confirmed by CT in 19 patients (40%), V/Q in 26 patients (55%) and leg ultrasound in one (2%). One patient with symptoms of possible after 3 months follow up refused additional diagnostic procedures and was judged to have had. Nine of 331 patients died (2Æ7%). In one patient had been diagnosed at study entry and this patient was treated with anticoagulant therapy; the cause of death based on postmortem results was malignancy. One patient had a clinical probability score of 1Æ5 and D-dimer of 387 lg/l at entry; this patient committed suicide and had no reported signs or symptoms of before death. In seven patients CT or VQ scanning at study entry ruled out. The clinical probability score was 4 in 279 patients (84%) and >4 in 52 patients (16%). Of the 279 patients with a clinical probability score of 4, 108 patients (39%) had CRP levels <5 mg/l. In this group 94 patients (87%) had a D-dimer <500 lg/l and, according to the study protocol, no further diagnostic tests were performed and anticoagulation was withheld. Follow up was performed by visits to the outpatient clinic in 122 of the 170 patients (72%) and was done by telephone in all other patients. Table I. Patient baseline characteristics (n ¼ 331). Characteristic Number (%) or median (range) Age (years) 51 (18 95) Sex (female) 205 (61Æ9) Risk factors Paralysis or cast within 4 weeks 8 (2Æ4) Immobilization >3 d or surgery 19 (5Æ7) within 1 month Previous DVT or 30 (9Æ1) Immobilization in travel 26 (7Æ9) Known heart failure 10 (3Æ0) Known COPD 44 (13Æ3) Oral contraceptives or 50 (15Æ1) hormone replacement therapy Malignancy 3 (0Æ9) DVT, deep venous thrombosis;, pulmonary embolism; COPD, chronic obstructive pulmonary disease. During the 3-month follow-up period none of the 170 patients with a clinical probability score of 4 and D-dimer <500 lg/l had signs or symptoms of venous thromboembolism for which they contacted the primary care doctor or our hospital. At the 3-month follow-up date two patients had signs or symptoms of possible. In one patient V/Q lung scanning was normal. In the other patient, who refused further diagnostic testing, the clinical probability score had been 0-points, the CRP level 4 mg/l and the D-dimer level 351 lg/l. This patient was not treated with anticoagulants and was alive 1 year after study inclusion; the primary care doctor had diagnosed hyperventilation syndrome. For the study, this patient was judged to have had by lack of a definitive diagnostic exclusion. A total of 14 of the 108 patients with a clinical probability score of 4 and CRP levels <5 mg/l had D-dimer levels of 500 lg/l or more. None of these 14 patients was diagnosed to have by V/Q scan or helical CT scan. The results of the CRP and D-dimer tests according to the clinical risk category and the presence of are shown in Table II. Table III shows the diagnostic performance of the CRP test according to the clinical probability score. A full comparison of CRP and D-dimer data was not possible, while in patients with a clinical probability score of >4 no D-dimer assay was performed. In these high clinical probability patients a considerable chance of a possible was present and therefore V/Q or CT scanning was performed as soon as possible, regardless of laboratory results. The sensitivity for the CRP assay alone with a cut-off level of 5 mg/l was 95Æ7% (95% CI: ); 44 of 46 patients with diagnosed had CRP levels 5 mg/l. Specificity was 43Æ2% (95% CI: 37 49); 123 of 285 patients with ruled out had CRP levels <5 mg/l. The NPV for the CRP assay was 98Æ4% (95% CI: ); of the 125 patients with CRP level <5 mg/l two patients (one in each clinical risk category) were shown to have. When combined with a clinical probability score of 4 the sensitivity increased to 96Æ7% (95% CI: ). Specificity was 43Æ0% (95% CI: 37 49) and NPV increased to 99Æ1% (95% CI: ). The negative likelihood ratio was 12Æ9. The sensitivity for the D-dimer assay with a cut-off level of 500 lg/l when combined with a clinical probability score of 4 was 96Æ7% (95% CI: ); 29 of 30 patients with diagnosed had D-dimer levels 500 lg/l. Specificity was 67Æ9% (95% CI: 62 74); 169 of 249 patients with ruled out had D-dimer levels <500 lg/l. The NPV was 99Æ4% (95% CI: ); of the 170 patients with D-dimer level <500 lg/l one patient was shown to have. The negative likelihood ratio was 20Æ4. The areas beneath the ROC curves, used to compare the discriminative power of the CRP and D-dimer test in the ruling out or diagnosing of were determined (Fig 1). The area under the ROC curve was 82Æ4% (95% CI: 77 88) for the CRP test and 92Æ5% (95% CI: 88 97) for the D-dimer test, implicating that the D-dimer assay was more accurate in ruling out or diagnosing. 616 ª 2005 Blackwell Publishing Ltd, British Journal of Haematology, 130,
4 C-reactive Protein in Pulmonary Embolism Table II. C-reactive protein and D-dimer in patients with and without by clinical probability score. C-reactive protein (n ¼ 331) D-dimer (n ¼ 279) <5 mg/l (n ¼ 125) 5 mg/l (n ¼ 206) <500 lg/l (n ¼ 170) 500 lg/l (n ¼ 109) (n ¼ 2) No (n ¼ 123) (n ¼ 44) No (n ¼ 162) (n ¼ 1) No (n ¼ 169) (n ¼ 29) No (n ¼ 80) Clinical probability score Unlikely Likely n.m. n.m. n.m. n.m. Values are expressed as number. n.m., not measured;, pulmonary embolism. Table III. Diagnostic performance of C-reactive protein (cut-off level 5 mg/l) by clinical probability score. Parameter, % (95% CI) C-reactive protein All patients (n ¼ 331) unlikely (n ¼ 279) likely (n ¼ 52) Sensitivity 95Æ7 (90 100) 96Æ7 (90 100) 93Æ8 (82 100) Specificity 43Æ2 (37 49) 43Æ0 (37 49) 44Æ4 (28 61) Positive predictive value 21Æ4 (16 27) 17Æ0 (11 23) 42Æ9 (26 59) Negative predictive value 98Æ4 (96 100) 99Æ1 (97 100) 94Æ1 (83 100), pulmonary embolism; CI, confidence interval. Discussion In this retrospective study, we have demonstrated that CRP, using a cut-off level of 5 mg/l, has a high sensitivity for the diagnosis of, comparable with D-dimer. This high sensitivity and high NPV in combination with a clinical probability score are in contrast to a recently published study, in which a more modest NPV of 87% was observed (Aujesky et al, 2003). The observed differences in NPVs are most likely partly due to the result of the lower prevalence of in our study population, i.e. 14% vs. 30% in the previous study (Aujesky et al, 2003). The negative likelihood ratio of the CRP assay was 12Æ9 compared with 20Æ4 for the D-dimer assay. Both the CRP and D-dimer tests had 99% NPV when combined with a clinical probability score. However, the specificity of the CRP test in patients with clinical probability score indicating unlikely was 43Æ0% compared with a specificity of 67Æ9% for the D-dimer test. This indicates that less invasive, time-consuming and expensive additional diagnostic procedures are needed when a D-dimer test is used compared with the CRP test and therefore this seems a better option in our opinion than the use of CRP. This is supported by the fact that there was a clear difference in negative likelihood ratios, suggesting that the high NPV of the CRP assay may indeed have been influenced by the lower prevalence of in our population. However, the CRP assay is cheap and readily available 24 h a day in most hospitals, in comparison with the D-dimer assay. As a full cost-effectiveness analysis was not performed as part of this study, future studies should take this into consideration. Several points need comment First, ultrasensitive CRP assays have recently been developed and can accurately detect CRP levels <5 mg/l. Our results demonstrate, however, that the standard CRP test has a 99Æ1% NPV and ultrasensitive CRP assays are in our view not necessary in the management strategy of excluding. Secondly, CRP levels 5 mg/l are non-specific as CRP levels rise in any inflammatory condition, including bacterial, viral or fungal infections, rheumatoid syndromes, cancer, pregnancy and atherosclerotic disease. The mechanism by which CRP is raised in venous thromboembolism is not yet completely understood. It is suggested that its ability to induce tissue factor expression on monocytes plays an important role (Cermak et al, 1993). Clinicians should be aware that in the management strategy of venous thromboembolism only CRP levels <5 mg/l are indicative of absence of ; CRP levels 5 mg/l do not implicate that is present, only that there is an inflammatory condition present. Thirdly, the question arises whether future studies should consider different cut-off levels for CRP. Our ROC analysis showed that a cut-off level of 6 mg/l would have resulted in a sensitivity of 95Æ7%, equal with the cut-off of 5 mg/l, and specificity of 48Æ1%, slightly higher than with the cut-off of 5 mg/l. Higher cut-off levels would have resulted in sensitivities below 95%, which is not acceptable when dealing with such a possibly fatal condition as. Lower cut-off levels would have resulted in very low specificities, leading to too many false-positive results. Also, given the fact that other studies demonstrated a cut-off level of 5 mg/l as optimal in ª 2005 Blackwell Publishing Ltd, British Journal of Haematology, 130,
5 N. Steeghs et al A Sensitivity specificity B that the two patients that were lost to follow up indeed developed, so these results are highly speculative. The strengths of our study include the novel design in diagnostics with CRP testing and clinical probability assessment with a validated rule, the prospective collection of follow-up data, and the independent assessment of outcome. Limitations of our study include the retrospective design, the relatively low prevalence of in comparison with other studies and absence of D-dimer data in patients with a clinical probability score >4. In conclusion, based on retrospective data it is concluded that a standard CRP test using a cut-off level of 5 mg/l can potentially be used to safely exclude, either as a sole test or combined with clinical probability assessment. Prospective studies are needed to confirm these findings Acknowledgements The Regio- Study Group consisted of: Rijnland Hospital, Leiderdorp R.W.L.M. Niessen, H. Dik, G.J.P.M. Jonkers and N. Steeghs; Diaconessen Hospital, Leiden R.W.L.M. Niessen, H.C.J. van Klink and E.V. Planken; Bronovo Hospital, Den Haag Th. Vlasveld, E.A.M. Werker-van Gelder, R. Bieger and A. Castel; Leiden University Medical Centre M.V. Huisman, H. Putter, N. Steeghs and R. J. Goekoop. Sensitivity specificity Fig 1. Receiver operating characteristics (ROC) curves. (A) C-reactive protein ROC curve; (B) D-dimer ROC curve. their population, we considered 5 mg/l as the optimum CRP cut-off level. In our opinion these data suggest that more research for other CRP cut-off levels is no longer needed. Fourthly, if the two patients that were lost to follow up were included and had been given a diagnosis of, sensitivities of CRP and D-dimer combined with the clinical probability score would have been 96Æ9 (95% CI: ) and 90Æ6% (95% CI: ), specificities 43Æ0 (95% CI: 37 49) and 67Æ9% (95% CI: 62 74) and NPV 99Æ1 (95% CI: ) and 98Æ3% (95% CI: ). This indicates that CRP could have been a better alternative to D-dimer if a larger population could have been included in the study. However, there is no reason to assume References Aujesky, D., Hayoz, D., Yersin, B., Perrier, A., Barghouth, G., Schnyder, P., Bischof-Delaloye, A. & Cornuz, J. (2003) Exclusion of pulmonary embolism using C-reactive protein and D-dimer. A prospective comparison. Thrombosis and Haemostasis, 90, Bucek, R.A., Reiter, M., Quehenberger, P. & Minar, E. (2002) C-reactive protein in the diagnosis of deep vein thrombosis. British Journal of Haematology, 119, Cermak, J., Key, N.S., Bach, R.R., Balla, J., Jacob, H.S. & Vercellotti, G.M. (1993) C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood, 82, Cooper, T.J., Prothero, D.L., Gillett, M.G., Pallister, C.J., Mitchelmore, A.E., Goddard, P.R., Wallington, T.B. & Hartog, M. (1992) Laboratory investigation in the diagnosis of pulmonary thromboembolism. Quarterly Journal of Medicine, 83, Franco, J.A., Gonzalez-Mangers, E. & Butler, T.T. (1994) Negative predictive value of C-reactive protein testing. Journal of Nuclear Medicine, 35, Ginsberg, J.S., Wells, P.S., Brill-Edwards, P., Donovan, D., Panju, A., van Beek, E.J. & Patel, A. (1995) Application of a novel and rapid whole blood assay for D-dimer in patients with clinically suspected pulmonary embolism. Thrombosis and Haemostasis, 73, Horney, E. & Lagerstedt, C. (1998) Evaluation of analyses to exclude suspected thrombosis. Don t rely on the D-dimer test! Lakartidningen, 95, Jossang, B. & Runde, I. (1992) Diagnostic value of C-reactive protein and D-dimer in deep venous thrombosis. Tidsskrift for den Norske laegeforening, 112, ª 2005 Blackwell Publishing Ltd, British Journal of Haematology, 130,
6 C-reactive Protein in Pulmonary Embolism Maskell, N.A. & Butland, R.J. (2001) A normal serum CRP measurement does not exclude deep vein thrombosis. Thrombosis and Haemostasis, 86, Perrier, A., Howarth, N., Didier, D., Loubeyre, P., Unger, P.F., de Moerloose, P., Slosman, D., Junod, A. & Bounameaux, H. (2001) Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism. Annals of Internal Medicine, 135, Perrier, A., Roy, P.M., Aujesky, D., Chagnon, I., Howarth, N., Gourdier, A.L., Leftheriotis, G., Barghouth, G., Cornuz, J., Hayoz, D. & Bounameaux, H. (2004) Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study. American Journal of Medicine, 116, Roumen-Klappe, E.M., den Heijer, M., van Uum, S.H., van der Ven- Jongekrijg, J., van der Graaf, F. & Wollersheim, H. (2002) Inflammatory response in the acute phase of deep vein thrombosis. Journal of Vascular Surgery, 35, Syrjala, H., Haukipuro, K. & Kiviniemi, H. (1990) Acute phase response and deep lower limb venous thrombosis. Journal of Clinical Pathology, 43, The PIOD Investigators (1990) Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOD). The PIOD Investigators. Journal of the American Medical Association, 263, Thomas, E.A., Cobby, M.J., Rhys, D.E., Jeans, W.D. & Whicher, J.T. (1989) Liquid crystal thermography and C reactive protein in the detection of deep venous thrombosis. British Medical Journal, 299, Wells, P.S., Ginsberg, J.S., Anderson, D.R., Kearon, C., Gent, M., Turpie, A.G., Bormanis, J., Weitz, J., Chamberlain, M., Bowie, D., Barnes, D. & Hirsh, J. (1998) Use of a clinical model for safe management of patients with suspected pulmonary embolism. Annals of Internal Medicine, 129, Wells, P.S., Anderson, D.R., Rodger, M., Ginsberg, J.S., Kearon, C., Gent, M., Turpie, A.G., Bormanis, J., Weitz, J., Chamberlain, M., Bowie, D., Barnes, D. & Hirsh, J. (2005) Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thrombosis and Haemostasis, 83, Wong, N.A., Laitt, R.D., Goddard, P.R. & Virjee, J. (1996) Serum C reactive protein does not reliably exclude lower limb deep venous thrombosis. Thrombosis and Haemostasis, 76, ª 2005 Blackwell Publishing Ltd, British Journal of Haematology, 130,
Citation for published version (APA): Douma, R. A. (2010). Pulmonary embolism: advances in diagnosis and prognosis
UvA-DARE (Digital Academic Repository) Pulmonary embolism: advances in diagnosis and prognosis Douma, R.A. Link to publication Citation for published version (APA): Douma, R. A. (2010). Pulmonary embolism:
More informationChapter 3. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism
Chapter 3 Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism F.A. Klok, I.C.M. Mos, M. Nijkeuter, M. Righini, A. Perrier, G. Le Gal and M.V. Huisman Arch
More informationC-reactive protein in the diagnosis of deep vein thrombosis
British Journal of Haematology, 2002, 119, 385 389 C-reactive protein in the diagnosis of deep vein thrombosis Robert A. Bucek, 1 Markus Reiter, 1 Peter Quehenberger 2 and Erich Minar 1 1 University Clinic
More informationCitation for published version (APA): Douma, R. A. (2010). Pulmonary embolism: advances in diagnosis and prognosis
UvA-DARE (Digital Academic Repository) Pulmonary embolism: advances in diagnosis and prognosis Douma, R.A. Link to publication Citation for published version (APA): Douma, R. A. (2010). Pulmonary embolism:
More informationUniversity of Groningen
University of Groningen Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: A retrospective analysis of three large cohorts Douma, Renée
More informationFrom the Departments of Medicine, University of Ottawa, Ottawa, Canada, McMaster University, Hamilton, Canada, Dalhousie University, Halifax, Canada
2000 Schattauer Verlag, Stuttgart Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer Philip S. Wells,
More informationDifferences in clinical presentation of pulmonary embolism in women and men
Journal of Thrombosis and Haemostasis, 8: 693 698 DOI: 10.1111/j.1538-7836.2010.03774.x ORIGINAL ARTICLE Differences in clinical presentation of pulmonary embolism in women and men H. ROBERT-EBADI,* G.
More informationClinical experience and pre-test probability scores in the diagnosis of pulmonary embolism
Q J Med 2003; 96:211 215 doi:10.1093/qjmed/hcg027 Clinical experience and pre-test probability scores in the diagnosis of pulmonary embolism S. ILES, A.M. HODGES, J.R. DARLEY, C. FRAMPTON 1,M.EPTON,L.E.L.BECKERT
More informationORIGINAL INVESTIGATION
ORIGINAL INVESTIGATION Clinical Usefulness of D-Dimer Depending on Clinical Probability and Cutoff Value in Outpatients With Suspected Pulmonary Embolism Marc Righini, MD; Drahomir Aujesky, MD; Pierre-Marie
More informationORIGINAL INVESTIGATION
Use of a Clinical Decision Rule in Combination With D-Dimer Concentration in Diagnostic Workup of Patients With Suspected Pulmonary Embolism A Prospective Management Study ORIGINAL INVESTIGATION Marieke
More informationClinically Suspected Acute Recurrent Pulmonary Embolism: A Diagnostic Challenge
7 Clinically Suspected Acute Recurrent Pulmonary Embolism: A Diagnostic Challenge M. Nijkeuter, H. Kwakkel- van Erp, M. Sohne, L.W. Tick, M.J.H.A. Kruip, E.F. Ullmann, M.H.H Kramer, H.R. Büller, M.H. Prins,
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/21764 holds various files of this Leiden University dissertation. Author: Mos, Inge Christina Maria Title: A more granular view on pulmonary embolism Issue
More informationD-dimer Value more than 3.6 μg/ml is Highly Possible Existence Deep Vein Thrombosis
Original Contribution This is Advance Publication Article Kurume Medical Journal, 60, 00-00, 2013 D-dimer Value more than 3.6 μg/ml is Highly Possible Existence Deep Vein Thrombosis SHINICHI NATA, SHINICHI
More informationMost primary care patients with suspected
Excluding deep vein thrombosis safely in primary care Validation study of a simple diagnostic rule D. B. Toll, MSc, R. Oudega, MD, PhD, R. J. Bulten, MD, A.W. Hoes, MD, PhD, K. G. M. Moons, PhD Julius
More informationClinical Guide - Suspected PE (Reviewed 2006)
Clinical Guide - Suspected (Reviewed 2006) Principal Developer: B. Geerts Secondary Developers: C. Demers, C. Kearon Background Investigation of patients with suspected pulmonary emboli () remains problematic
More informationBACKGROUND METHODS RESULTS CONCLUSIONS
CHAPTER 5 The combination of a normal D-dimer concentration and a non-high pretest clinical probability score is a safe strategy to exclude deep venous thrombosis R.E.G. Schutgens 1, P. Ackermark 2, F.J.L.M.
More informationSAFETY OF A PULMONARY EMBOLISM AMBULATORY TREATMENT PROGRAM
SAFETY OF A PULMONARY EMBOLISM AMBULATORY TREATMENT PROGRAM Mahir M. Hamad 1, MD, FRCP, Elrasheed A. Ellidir 1, MD, MRCP, Charlotte Routh 1, MD, MRCP, Siraj O. Wali 2, FACP, FCCP, and Vincent M. Connolly
More informationSimplified approach to investigation of suspected VTE
Simplified approach to investigation of suspected VTE Diagnosis of DVT and PE THSNA 2016, Chicago 15 April 2016 Clive Kearon, McMaster University, Canada Relevant Disclosures Research Support/P.I. Employee
More informationInflammatory response in the acute phase of deep vein thrombosis
Inflammatory response in the acute phase of deep vein thrombosis Edith M. Roumen-Klappe, MD, a Martin den Heijer, MD, PhD, b,c Stan H. M. van Uum, MD, c Johanna van der Ven-Jongekrijg, MS, d Fedde van
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/40114 holds various files of this Leiden University dissertation Author: Exter, Paul L. den Title: Diagnosis, management and prognosis of symptomatic and
More informationThe Modified Wells Score Accurately Excludes Pulmonary Embolus in Hospitalized Patients Receiving Heparin Prophylaxis
ORIGINAL RESEARCH The Modified Wells Score Accurately Excludes Pulmonary Embolus in Hospitalized Patients Receiving Heparin Prophylaxis Amit Bahia, MD 1,2 Richard K. Albert, MD 1,2 1 Department of Medicine,
More informationCitation for published version (APA): Mac Gillavry, M. R. (2001). Some understanding of diagnostic tests for pulmonary embolism
UvA-DARE (Digital Academic Repository) Some understanding of diagnostic tests for pulmonary embolism Mac Gillavry, M.R. Link to publication Citation for published version (APA): Mac Gillavry, M. R. (2001).
More informationDiagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism
Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary Embolism Summary Number 68 Overview Venous thromboembolism
More informationProper Diagnosis of Venous Thromboembolism (VTE)
Proper Diagnosis of Venous Thromboembolism (VTE) Whal Lee, M.D. Seoul National University Hospital Department of Radiology 2 nd EFORT Asia Symposium, 3 rd November 2010, Taipei DVT - Risk Factors Previous
More informationCitation for published version (APA): Mac Gillavry, M. R. (2001). Some understanding of diagnostic tests for pulmonary embolism
UvA-DARE (Digital Academic Repository) Some understanding of diagnostic tests for pulmonary embolism Mac Gillavry, M.R. Link to publication Citation for published version (APA): Mac Gillavry, M. R. (2001).
More informationIn recent years, extensive research has been devoted to
CLINICIAL STUDIES Diagnosing Pulmonary Embolism in Outpatients with Clinical Assessment, D-Dimer Measurement, Venous Ultrasound, and Helical Computed Tomography: A Multicenter Management Study Arnaud Perrier,
More informationPulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical
Pulmonary embolus - a practical approach to investigation and treatment Sam Janes Wellcome Senior Fellow and Respiratory Physician, University College London Background Diagnosis Treatment Common: 50 cases
More informationsuspected deep-vein thrombosis is a common condition, with a lifetime cumulative incidence of 2 to 5 percent. Untreated deep-vein thrombosis can resul
original article Evaluation of d-dimer in the Diagnosis of Suspected Deep-Vein Thrombosis Philip S. Wells, M.D., David R. Anderson, M.D., Marc Rodger, M.D., Melissa Forgie, M.D., Clive Kearon, M.D., Ph.D.,
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/40114 holds various files of this Leiden University dissertation Author: Exter, Paul L. den Title: Diagnosis, management and prognosis of symptomatic and
More informationDeep Vein Thrombosis: Can a Second Sonographic Examination Be Avoided?
Alfonsa Friera 1 Nuria R. Giménez 2 Paloma Caballero 1 Pilar S. Moliní 2 Carmen Suárez 2 Received August 15, 2001; accepted after revision October 16, 2001. 1 Radiology Department, Hospital de la Princesa,
More informationACR Appropriateness Criteria Suspected Lower Extremity Deep Vein Thrombosis EVIDENCE TABLE
. Fowkes FJ, Price JF, Fowkes FG. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 003; 5():-5.. Hamper UM, DeJong MR, Scoutt LM. Ultrasound
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/188/20915 holds various files of this Leiden University dissertation. Author: Flinterman, Linda Elisabeth Title: Risk factors for a first and recurrent venous
More informationDiagnostic Algorithms in VTE
Diagnostic Algorithms in VTE Mark H. Meissner, MD Department of Surgery University of Washington School of Medicine Overutilization of Venous Duplex U/S 1983-1993 (Zweibel et al, Australasian Rad, 1995)
More informationComparison of a Clinical Probability Estimate and Two Clinical Models in Patients with Suspected Pulmonary Embolism
2000 Schattauer Verlag, Stuttgart Thromb Haemost 2000; 83: 199 203 Comparison of a Clinical Probability Estimate and Two Clinical Models in Patients with Suspected Pulmonary Embolism Bernd-Jan Sanson 1,
More informationHow to Diagnose Pulmonary Embolism anno 2014?
How to Diagnose Pulmonary Embolism anno 2014? Mark H.H. Kramer, MD, PhD, FRCP FACP Professor of Medicine VU University Medical Center Amsterdam, The Netherlands What are we going to discuss? Age adjusted
More informationCitation for published version (APA): Mac Gillavry, M. R. (2001). Some understanding of diagnostic tests for pulmonary embolism
UvA-DARE (Digital Academic Repository) Some understanding of diagnostic tests for pulmonary embolism Mac Gillavry, M.R. Link to publication Citation for published version (APA): Mac Gillavry, M. R. (2001).
More informationPredictive Accuracy of Revised Geneva Score in the Diagnosis of Pulmonary Embolism
ORIGINAL ARTICLE Tanaffos (2009) 8(4), 7-13 2009 NRITLD, National Research Institute of Tuberculosis and Lung Disease, Iran Predictive Accuracy of Revised Geneva Score in the Diagnosis of Pulmonary Embolism
More informationMultidetector-Row Computed Tomography in Suspected Pulmonary Embolism
The new england journal of medicine original article Multidetector-Row Computed Tomography in Suspected Pulmonary Embolism Arnaud Perrier, M.D., Pierre-Marie Roy, M.D., Olivier Sanchez, M.D., Grégoire
More informationEenduidige diagnostiek van longembolie: progress after YEARS
Eenduidige diagnostiek van longembolie: progress after YEARS Menno Huisman Department of Thrombosis and Hemostasis Leiden University Medical Center, Leiden, the Netherlands Disclosures MV Huisman None
More informationPatients with suspected DVT of the lower limb how to exam the patient
Patients with suspected DVT of the lower limb how to exam the patient Johannes Godt Dep. of Radiology and Nuclear Medicine Oslo University Hospital Ullevål NORDTER 2015, Oslo Content Anatomy and pathophysiology
More informationProvider Led Entity. CDI Quality Institute PLE Chest / Pulmonary Embolus AUC 07/31/2018
Provider Led Entity CDI Quality Institute PLE Chest / Pulmonary Embolus AUC 07/31/2018 Appropriateness of advanced imaging procedures* in patients with suspected or known pulmonary embolus and the following
More informationORIGINAL INVESTIGATION
ORIGINAL INVESTIGATION A Latex D-Dimer Reliably Excludes Venous Thromboembolism Shannon M. Bates, MD, CM; Anne Grand Maison, MD; Marilyn Johnston, ART; Ivy Naguit, MLT; Michael J. Kovacs, MD; Jeffrey S.
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/40114 holds various files of this Leiden University dissertation Author: Exter, Paul L. den Title: Diagnosis, management and prognosis of symptomatic and
More informationPulmonary embolism? A rapid disposition can be a matter of life or death.
Pulmonary embolism? A rapid disposition can be a matter of life or death. Not all D-dimer tests are created equal. D-dimer assays are known to have varying sensitivities. 8,9,10 ELISA and FIA assays have
More informationAge-adjusted vs conventional D-dimer thresholds in the diagnosis of venous thromboembolism
James Madison University JMU Scholarly Commons Physician Assistant Capstones The Graduate School 5-16-2017 Age-adjusted vs conventional D-dimer thresholds in the diagnosis of venous thromboembolism Kirsten
More informationProspective Validation of Wells Criteria in the Evaluation of Patients With Suspected Pulmonary Embolism
PULMONARY/ORIGINAL RESEARCH Prospective Validation of Wells Criteria in the Evaluation of Patients With Suspected Pulmonary Embolism Stephen J. Wolf, MD Tracy R. McCubbin, MD Kim M. Feldhaus, MD Jeffrey
More informationD-dimer Testing for Suspected Pulmonary Embolism in Outpatients
D-dimer Testing for Suspected Pulmonary Embolism in Outpatients ARNAUD PERRIER, SYLVIE DESMARAIS, CATHERINE GOEHRING, PHILIPPE de MOERLOOSE, ALFREDO MORABIA, PIERRE-FRANÇOIS UNGER, DANIEL SLOSMAN, ALAIN
More informationImpact of Delay in Clinical Presentation on the Diagnostic Management and Prognosis of Patients with Suspected Pulmonary Embolism
Impact of Delay in Clinical Presentation on the Diagnostic Management and Prognosis of Patients with Suspected Pulmonary Embolism Paul L. den Exter 1 *, Josien van Es 2 *, Petra M. G. Erkens 3, Mark J.
More informationChapter 1. Introduction
Chapter 1 Introduction Introduction 9 Even though the first reports on venous thromboembolism date back to the 13 th century and the mechanism of acute pulmonary embolism (PE) was unraveled almost 150
More informationEffectiveness of managing suspected pulmonary. embolism using an algorithm combining clinical. probability, D-dimer testing, and computed tomography
CHAPTER 3 Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography A. van Belle, H.R. Büller, M.V. Huisman, P.
More informationClinical prediction rules for pulmonary embolism: a systematic review and meta-analysis
Journal of Thrombosis and Haemostasis, 8: 957 970 DOI: 10.1111/j.1538-7836.2010.03801.x ORIGINAL ARTICLE Clinical prediction rules for pulmonary embolism: a systematic review and meta-analysis E. CERIANI,*
More informationSupplementary Online Content
Supplementary Online Content Mismetti P, Laporte S, Pellerin O, Ennezat P-V, Couturaud F, Elias A, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone
More informationHayden Smith, PhD, MPH /\ v._
Hayden Smith, PhD, MPH.. + /\ v._ Information and clinical examples provided in presentation are strictly for educational purposes, and should not be substituted for clinical guidelines or up-to-date medical
More informationTriage D-Dimer Test. Pulmonary embolism? A rapid disposition can be a matter of life or death.
BR9810000EN00.qxp_Layout 1 3/6/18 11:56 AM Page 3 Triage D-Dimer Test Pulmonary embolism? A rapid disposition can be a matter of life or death. SL2713 BR9810000EN00 (03/18) BR9810000EN00.qxp_Layout 1 3/6/18
More informationScanning the Literature
Scanning the Literature Joseph Breault, MD, MPHTM Joseph Guarisco, MD Spiral CTs Are Cost-Effective Paterson DI, Schwartzman K. Strategies incorporating spiral CT for the diagnosis of acute pulmonary embolism:
More informationThe diagnosis and prognosis of venous thromboembolism : variations on a theme Gibson, N.S.
UvA-DARE (Digital Academic Repository) The diagnosis and prognosis of venous thromboembolism : variations on a theme Gibson, N.S. Link to publication Citation for published version (APA): Gibson, N. S.
More informationM ortality from pulmonary embolic disease has
123 ORIGINAL ARTICLE Outpatient diagnosis of pulmonary embolism: the MIOPED (Manchester Investigation Of Pulmonary Embolism Diagnosis) study K Hogg, D Dawson, K Mackway-Jones... See end of article for
More informationD-Dimer in Patients With Clinically Suspected Pulmonary Embolism*
D-Dimer in Patients With Clinically Suspected Pulmonary Embolism* JeffreyS. Ginsberg, M.D. F.C.C.P.; Patrick A. Brill-Edwards, M.D., F.C.C.P. ; Christine Demers, M.D.; Dianne Donovan, R.N.; and Akbar Panju,
More informationTiming of NT-pro-BNP sampling for predicting adverse outcome after acute pulmonary embolism
7 Frederikus A. Klok Noortje van der Bijl Inge C.M. Mos Albert de Roos Lucia J. M. Kroft Menno V. Huisman Timing of NT-pro-BNP sampling for predicting adverse outcome after acute pulmonary embolism Letter
More informationTHE MAIN CHALLENGE IN THE DIagnostic
ORIGINAL CONTRIBUTION Effectiveness of Managing Suspected Pulmonary Embolism Using an Algorithm Combining Clinical Probability, D-Dimer Testing, and Computed Tomography Writing Group for the Christopher
More informationAssessment of the safety using age adjusted D-dimer to rule out venous thromboembolism in a Swedish Emergency Department
Assessment of the safety using age adjusted D-dimer to rule out venous thromboembolism in a Swedish Emergency Department Herman Tagger 1, Helene Kildegaard Jensen 2, Annmarie Touborg Lassen 2, Ulf Ekelund
More informationORIGINAL INVESTIGATION. The Bedside Investigation of Pulmonary Embolism Diagnosis Study
ORIGINAL INVESTIGATION The Bedside Investigation of Pulmonary Embolism Diagnosis Study A Double-blind Randomized Controlled Trial Comparing Combinations of 3 Bedside Tests vs Ventilation-Perfusion Scan
More informationWhat You Should Know
1 New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know New 2018 ASH Clinical Practice Guidelines on Venous Thromboembolism: What You Should Know The American Society
More informationCURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow
CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired
More informationDeep Vein Thrombosis and Pulmonary Embolism: Patient Information
Deep Vein Thrombosis and Pulmonary Embolism: Patient Information A Deep Vein Thrombosis (DVT) and a Pulmonary Embolism (PE) are both disorders of unwanted blood clotting. Unwanted blood clots can occur
More informationORIGINAL INVESTIGATION. The Impact of the Introduction of a Rapid D-Dimer Assay on the Diagnostic Evaluation of Suspected Pulmonary Embolism
ORIGINAL INVESTIGATION The Impact of the Introduction of a Rapid D-Dimer Assay on the Diagnostic Evaluation of Suspected Pulmonary Embolism Nir M. Goldstein, MD; Marin H. Kollef, MD; Suzanne Ward, RN;
More informationPulmonary embolism (PE) remains a diagnostic challenge,
Comparison of Observer Variability and Accuracy of Different Criteria for Lung Scan Interpretation Petronella J. Hagen, MD 1,2 ; Ieneke J.C. Hartmann, PhD 3,4 ; Otto S. Hoekstra, PhD 2,5 ; Marcel P.M.
More informationDiagnostic methods in pulmonary embolism
2 Diagnostic methods in pulmonary embolism M. Nijkeuter, M.V. Huisman European Journal of Internal Medicine 2005; 16: 247-256 Palazzo Podesta, Bologna, Italia Nijkeuter_V4.indd 15 02-05-2007 15:09:16 Chapter
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/20073 holds various files of this Leiden University dissertation. Author: Zondag, Wendy Title: Pulmonary embolism : outpatient treatment and risk stratification
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/19768 holds various files of this Leiden University dissertation. Author: Langevelde, Kirsten van Title: Are pulmonary embolism and deep-vein thrombosis
More informationThe Role of D-Dimer in the Diagnosis of Venous Thromboembolism
science [chemistry coagulation and hematology] The Role of D-Dimer in the Diagnosis of Venous Thromboembolism Donald H. Schreiber MD, CM FRCPC FACEP Division of Emergency Medicine, Stanford University
More informationNo influence of heparin plasma and other (pre)analytic variables on D-dimer determination
CHAPTER 2 No influence of heparin plasma and other (pre)analytic variables on D-dimer determination R.E.G. Schutgens 1, F.J.L.M. Haas 2, H.J.T. Ruven 2, M. Spannagl 3, K. Horn 3, D.H. Biesma 1 Departments
More informationRecognition of or ruling out deep venous thrombosis
Article The Wells Rule Does Not Adequately Rule Out Deep Venous Thrombosis in Primary Care Patients Ruud Oudega, MD; Arno W. Hoes, MD, PhD; and Karel G.M. Moons, PhD Background: Using data from secondary
More informationVENOUS THROMBOEMBOLISM: DURATION OF TREATMENT
VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT OBJECTIVE: To provide guidance on the recommended duration of anticoagulant therapy for venous thromboembolism (VTE). BACKGROUND: Recurrent episodes of VTE
More informationDeveloping a research question The research question
Developing a research question The research question The research question for a systematic review should specify the types of population (participants), types of interventions (and comparisons), and the
More informationVTE General Background
VTE General Background VTE incidence is about 1:1000 persons annually >250,000 admissions for VTE annually >100,000 people die of PE annually >90% of PE s arise from lower limb DVT 50% of DVT at diagnosis
More informationEmergency physicians commonly measure quantitative
ORIGINAL CONTRIBUTION D-dimer Interval Likelihood Ratios for Pulmonary Embolism Michael A. Kohn, MD, MPP, Frederikus A. Klok, MD, PhD, and Nick van Es, MD ABSTRACT Objective: The objective was to estimate
More informationRecurrence risk after anticoagulant treatment of limited duration for late, second venous thromboembolism
ARTICLES Coagulation & its Disorders Recurrence risk after anticoagulant treatment of limited duration for late, second venous thromboembolism Tom van der Hulle, Melanie Tan, Paul L. den Exter, Mark J.G.
More informationNew Criteria for Ventilation-Perfusion Lung Scan Interpretation: A Basis for Optimal Interaction with Helical CT Angiography 1
1206 July-August 2000 RG Volume 20 Number 4 New Criteria for Ventilation-Perfusion Lung Scan Interpretation: A Basis for Optimal Interaction with Helical CT Angiography 1 Alexander Gottschalk, MD Introduction
More informationmultidetector computed tomographic pulmonary angiography in patients with a high clinical probability of pulmonary embolism
Journal of Thrombosis and Haemostasis, 14: 114 12 DOI: 1.1111/jth.13188 ORIGINAL ARTICLE Multidetector computed tomographic pulmonary angiography in patients with a high clinical probability of pulmonary
More informationA low probability interpretation of a ventilation/
Very Low Probability Interpretation of V/Q Lung Scans in Combination with Low Probability Objective Clinical Assessment Reliably Excludes Pulmonary Embolism: Data from PIOPED II Alexander Gottschalk 1,
More informationToo much medicine and venous thromboembolism: How can we make things Well again?
Too much medicine and venous thromboembolism: How can we make things Well again? Emily G McDonald MD MSc; Assistant professor of medicine; McGill University Health Centre Canadian Society of Internal Medicine;
More informationDiagnosis of Deep Venous Thrombosis and Pulmonary Embolism
Diagnosis of Deep Venous Thrombosis and Pulmonary Embolism JASON WILBUR, MD, and BRIAN SHIAN, MD, Carver College of Medicine, University of Iowa, Iowa City, Iowa Venous thromboembolism manifests as deep
More informationORIGINAL INVESTIGATION. Assessing Clinical Probability of Pulmonary Embolism in the Emergency Ward. tools (leg vein ultrasonography 1-4 and plasma
Assessing Clinical Probability of Pulmonary Embolism in the Emergency Ward A Simple Score ORIGINAL INVESTIGATION Jacques Wicki, MD; Thomas V. Perneger, MD, PhD; Alain F. Junod, MD; Henri Bounameaux, MD;
More informationUltrasonography and Diagnosis of Venous Thromboembolism
Ultrasonography and Diagnosis of Venous Thromboembolism Brenda K. Zierler, PhD Abstract Venous thromboembolism (VTE) consists of two related conditions: pulmonary embolism (PE) and deep vein thrombosis
More informationThe diagnosis and prognosis of venous thromboembolism : variations on a theme Gibson, N.S.
UvA-DARE (Digital Academic Repository) The diagnosis and prognosis of venous thromboembolism : variations on a theme Gibson, N.S. Link to publication Citation for published version (APA): Gibson, N. S.
More informationDiagnosis, treatment and long-term effects of venous thromboembolism Cheung, Whitney
UvA-DARE (Digital Academic Repository) Diagnosis, treatment and long-term effects of venous thromboembolism Cheung, Whitney Link to publication Citation for published version (APA): Cheung, Y. W. (2016).
More informationHigh D-dimer levels increase the likelihood of pulmonary embolism
Original Article doi: 10.1111/j.1365-2796.2008.01972.x High D-dimer levels increase the likelihood of pulmonary embolism L. W. Tick 1, M. Nijkeuter 2, M. H. H. Kramer 1, M. M. C. Hovens 2,H.R.Büller 3,
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 16 December 1999 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON CLINICAL
More informationUnderutilization of Evidence-based Strategies in the Diagnosis and Treatment of Venous Thromboembolism Among Trainees
ORIGINAL RESEARCH Underutilization of Evidence-based Strategies in the Diagnosis and Treatment of Venous Thromboembolism Among Trainees Vibhu Sharma, MD Charles Koczka, MD Conrad Fischer, MD Department
More informationVenous Thromboembolism (VTE)
Venous Thromboembolism (VTE) Nursing A guide for patients and carers Contents Why do blood clots form in veins?... 1 How common is a deep vein thrombosis (DVT) or pulmonary embolus (PE)?... 2 How are DVTs/
More informationThe diagnosis and prognosis of venous thromboembolism : variations on a theme Gibson, N.S.
UvA-DARE (Digital Academic Repository) The diagnosis and prognosis of venous thromboembolism : variations on a theme Gibson, N.S. Link to publication Citation for published version (APA): Gibson, N. S.
More informationUnderuse of risk assessment and overuse of CTPA in patients with suspected pulmonary thromboembolism
Underuse of risk assessment and overuse of CTPA in patients with suspected pulmonary thromboembolism Michael Perera Advanced Trainee in General and Acute Medicine Leena Aggarwal Director, Medical Assessment
More informationAdjustments in the diagnostic work-up, treatment and prognosis of pulmonary embolism van Es, Josien
UvA-DARE (Digital Academic Repository) Adjustments in the diagnostic work-up, treatment and prognosis of pulmonary embolism van Es, Josien Link to publication Citation for published version (APA): van
More informationAppendix to Gibson et al. Application of a decision rule and a D-dimer assay in the
Appendix to Gibson et al. Application of a decision rule and a D-dimer assay in the diagnosis of pulmonary embolism (Thromb Haemost 2010; 103.4) Case 1 You are paged by an emergency room physician, who
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/40114 holds various files of this Leiden University dissertation Author: Exter, Paul L. den Title: Diagnosis, management and prognosis of symptomatic and
More informationPulmonary Thromboembolism
Pulmonary Thromboembolism James Allen, MD Epidemiology of Pulmonary Embolism 1,500,000 new cases per year in the United States Often asymptomatic 300,000 deaths per year DVT or PE present in 10% of ICU
More informationDeep venous thrombosis is a common condition that. Article
Article Negative D-Dimer Result To Exclude Recurrent Deep Venous Thrombosis: A Management Trial Suman W. Rathbun, MD, MS; Thomas L. Whitsett, MD; and Gary E. Raskob, PhD Background: All of the available
More information